EICHOR
● Active Not Recruiting
Iberdomide (Cc220) Maintenance After Asct in Newly Diagnosed MM Patients
Condition: Multiple Myeloma · Sponsor: Stichting European Myeloma Network
About this study
This is a phase II study to evaluate the efficacy and safety of different doses of iberdomide continuous therapy as maintenancetreatment after transplant.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (22)
| Centre Hospitalier Universitaire de Bordeaux | Bordeau, France | — |
| Centre Hospitalier Universitaire de Dijon | Dijon, France | — |
| CHU Hôtel-Dieu, 1, place Alexis Ricordeau, 44093 NANTES Cedex 1, FRANCE | Nantes, France | — |
| CHU Hôtel-Dieu | Nantes, France | — |
| Saint Antoine Hospital, Hematology Department | Paris, France | — |
| C.H.U. Strasbourg | Strasbourg, France | — |
| Institut Universitaire Du Cancer De Toulose | Toulouse, France | — |
| Alexandra General Hospital -Department of Clinical Therapeutics N.K. Univ. of Athens | Athens, Greece | — |
| Theagenio Cancer Hospital | Thessaloniki, Greece | — |
| A.O.U. Ospedali Riuniti Umberto I - G.M. Lancisi - G. Salesi di Ancona | Ancona, Italy | — |
| A.O.U. di Bologna - Policlinico S. Orsola Malpighi | Bologna, Italy | — |
| Ospedale Generale Regionale-Divisione di Ematologia e Centro Trapianto Midollo Osseo | Bolzano, Italy | — |
+ 10 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04564703